Robust DNA Damage Response and Elevated Reactive Oxygen Species in TINF2-Mutated Dyskeratosis Congenita Cells.

作者: Larisa Pereboeva , Meredith Hubbard , Frederick D. Goldman , Erik R. Westin

DOI: 10.1371/JOURNAL.PONE.0148793

关键词:

摘要: Dyskeratosis Congenita (DC) is an inherited multisystem premature aging disorder with characteristic skin and mucosal findings as well a predisposition to cancer bone marrow failure. DC arises due gene mutations associated the telomerase complex or telomere maintenance, resulting in critically shortened telomeres. The pathogenesis of DC, several congenital failure (BMF) syndromes, converges on DNA damage response (DDR) pathway subsequent elevation reactive oxygen species (ROS). Historically, patients have had poor outcomes following transplantation (BMT), perhaps consequence underlying hypersensitivity cytotoxic agents. Previously, we demonstrated activated DDR increased ROS, augmented by chemotherapy radiation, somatic cells isolated from mutation RNA component telomerase, TERC. current study was undertaken determine whether previous related ROS TERC patients’ could be extended other mutations. Of particular interest antioxidant approach counter decrease pathologies. To test this, examined lymphocytes different (TERT, TINF2, TERC) for presence active ROS. All led steady-state p53 (2-fold 10-fold) (1.5-fold 2-fold). Upon exposure ionizing radiation (XRT), both significant degree. Exposing hydrogen peroxide also revealed that maintain oxidant burden compared controls 3-fold). cell culture supplemented N-acetylcysteine, alternatively grown low oxygen, afforded proliferative benefits (proliferation: maximum 2-fold increase; NAC: 5-fold decrease; oxygen: 3.5-fold decrease). Together, our data supports mechanism whereby deficiency telomeres initiate create pro-oxidant environment, especially carrying TINF2 Finally, ameliorative effects antioxidants vitro suggest this translate therapeutic patients.

参考文章(49)
Bai-Wei Gu, Jian-Meng Fan, Monica Bessler, Philip J. Mason, Accelerated hematopoietic stem cell aging in a mouse model of dyskeratosis congenita responds to antioxidant treatment Aging Cell. ,vol. 10, pp. 338- 348 ,(2011) , 10.1111/J.1474-9726.2011.00674.X
Michael Kirwan, Richard Beswick, Amanda J. Walne, Upal Hossain, Colin Casimir, Tom Vulliamy, Inderjeet Dokal, Dyskeratosis congenita and the DNA damage response. British Journal of Haematology. ,vol. 153, pp. 634- 643 ,(2011) , 10.1111/J.1365-2141.2011.08679.X
James R. Mitchell, Emily Wood, Kathleen Collins, A telomerase component is defective in the human disease dyskeratosis congenita Nature. ,vol. 402, pp. 551- 555 ,(1999) , 10.1038/990141
Laura A. Sena, Sha Li, Amit Jairaman, Murali Prakriya, Teresa Ezponda, David A. Hildeman, Chyung-Ru Wang, Paul T. Schumacker, Jonathan D. Licht, Harris Perlman, Paul J. Bryce, Navdeep S. Chandel, Mitochondria Are Required for Antigen-Specific T Cell Activation through Reactive Oxygen Species Signaling Immunity. ,vol. 38, pp. 225- 236 ,(2013) , 10.1016/J.IMMUNI.2012.10.020
Christine Richardson, Shan Yan, C. Vestal, Oxidative Stress, Bone Marrow Failure, and Genome Instability in Hematopoietic Stem Cells International Journal of Molecular Sciences. ,vol. 16, pp. 2366- 2385 ,(2015) , 10.3390/IJMS16022366
Fabrizio d'Adda di Fagagna, Philip M. Reaper, Lorena Clay-Farrace, Heike Fiegler, Philippa Carr, Thomas von Zglinicki, Gabriele Saretzki, Nigel P. Carter, Stephen P. Jackson, A DNA damage checkpoint response in telomere-initiated senescence Nature. ,vol. 426, pp. 194- 198 ,(2003) , 10.1038/NATURE02118
K. R. Atkuri, L. A. Herzenberg, A.-K. Niemi, T. Cowan, L. A. Herzenberg, Importance of culturing primary lymphocytes at physiological oxygen levels. Proceedings of the National Academy of Sciences of the United States of America. ,vol. 104, pp. 4547- 4552 ,(2007) , 10.1073/PNAS.0611732104
Frederick D. Goldman, Geraldine Aubert, Al J. Klingelhutz, Mark Hills, Sarah R. Cooper, Wendy S. Hamilton, Annette J. Schlueter, Karen Lambie, Connie J. Eaves, Peter M. Lansdorp, Characterization of primitive hematopoietic cells from patients with dyskeratosis congenita. Blood. ,vol. 111, pp. 4523- 4531 ,(2008) , 10.1182/BLOOD-2007-10-120204
Philip J. Mason, Monica Bessler, The genetics of dyskeratosis congenita Cancer Genetics. ,vol. 204, pp. 635- 645 ,(2011) , 10.1016/J.CANCERGEN.2011.11.002
Erik R. Westin, Nukhet Aykin-Burns, Erin M. Buckingham, Douglas R. Spitz, Frederick D. Goldman, Aloysius J. Klingelhutz, The p53/p21WAF/CIP Pathway Mediates Oxidative Stress and Senescence in Dyskeratosis Congenita Cells with Telomerase Insufficiency Antioxidants & Redox Signaling. ,vol. 14, pp. 985- 997 ,(2011) , 10.1089/ARS.2010.3444